Clinical research
Resolve the agreements that hold up study activation.
Clinical-research agreements often delay study activation where responsibility for negotiation, indemnity, insurance, data, payment or institutional approval remains unresolved.
Who this is for
Sponsors, CROs, research institutions, sites, investigators, laboratories and vendors
Typically instructed by: Clinical operations · study start-up · site contracts and outsourcing · research contracts offices
Scope
What can be instructed
- Clinical trial agreements
- Sponsor-site, sponsor-institution and tripartite clinical trial agreements, including budget schedules and payment terms.
- Sponsor and CRO agreements
- Master services agreements, work orders, transfer of regulatory obligations and change-order mechanics.
- Site, institution and investigator contracts
- Research-institution contracts, site agreements, principal-investigator arrangements and sub-site structures.
- Laboratory and vendor agreements
- Central and local laboratory agreements, imaging, courier, IRT and other specialist vendor arrangements.
- Data and material arrangements
- Data-processing agreements, data-transfer arrangements and material transfer agreements for biological samples.
- Risk allocation
- Indemnity, insurance, publication, payment, termination and dispute provisions, and the escalation of disputed positions during start-up.
Before you instruct
What helps the firm assess the matter
- The parties to the agreement and any related entities, for the conflicts check.
- The protocol number or study identifier, and the sites or institutions involved.
- The template in use and whether it is the sponsor's, the institution's or a national template.
- The start-up deadline the programme is working to.
jw van zyl inc